Clear all search history
Law & Crime
Disasters & Accidents
War & Conflict
Hospitality & Recreation
donepezil articles over last 30 days
articles last 30 days
articles per day
Mentioned in this news
Forest Files NDA For Alzheimer’s Combination Ther...
... an NDA to the FDA for the fixed dose combination of memantine HCL extended release and
HCL as treatment for moderate to severe dementia related to Alzheimer’s disease. Forest...
Read more at PharmaceuticalOnline
Forest Laboratories plans to discontinue sale of ...
... the treatment of Alzheimer's disease, including the fixed-dose combination of NAMENDA XR and
, which is under development." Importantly, physicians can switch patients from NAMENDA to...
Read more at
Forest Laboratories Inc.
U.S. Food and Drug Administration
The Tyee – Family Fears BC Will Quit Covering Alz...
... long considered adding to coverage under the PharmaCare public drug plan. The other two are
(Aricept) and galantamine (Reminyl). The three drugs are controversial, with disagreement...
Read more at The Tyee
British Columbia government
Alzheimer Society of B.C.
Latest from Twitter
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.